CureVac
CVAC
CVAC was delisted on the 5th of January, 2026.
109 hedge funds and large institutions have $1.02B invested in CureVac in 2021 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 23 increasing their positions, 26 reducing their positions, and 28 closing their positions.
89% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 28
30% more funds holding
Funds holding: 84 → 109 (+25)
7% more call options, than puts
Call options by funds: $262M | Put options by funds: $246M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.09% less ownership
Funds ownership: 7.52% → 7.43% (-0.09%)
12% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 26
21% less capital invested
Capital invested by funds: $1.28B → $1.02B (-$266M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$106M |
| 2 |
State Street
Boston,
Massachusetts
|
+$46.8M |
| 3 |
Citigroup
New York
|
+$17.6M |
| 4 |
Nuveen
Charlotte,
North Carolina
|
+$15.5M |
| 5 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$15.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$137M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$39.4M |
| 3 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$31.5M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$21.6M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$16.3M |
CVAC Hedge Fund Activity: Q2 2021 in Review
109 of the 5,766 institutional investors tracked by Wall St. Rank reported a position in CureVac (CVAC) for Q2 2021, worth a combined $1.02B — down 21% from $1.28B a quarter earlier.
Buyers outnumbered sellers: 53 funds opened new CVAC positions and 28 closed out — a net gain of 25 holders — while 23 added to existing stakes and 26 trimmed.
The largest buyer was BlackRock, adding an estimated $106M. The largest seller was T. Rowe Price Associates, cutting an estimated $137M.
- 109 institutional investors held CureVac (CVAC) as of Q2 2021, up from 84 in Q1 2021.
- Funds reported $1.02B of CureVac stock for Q2 2021, down 21% quarter-over-quarter.
- 53 funds opened new CureVac positions in Q2 2021 and 28 closed out, a net change of +25 holders.
- The largest CureVac buyer in Q2 2021 was BlackRock, an estimated $106M added.
- The largest CureVac seller in Q2 2021 was T. Rowe Price Associates, an estimated $137M sold.
Based on aggregated 13F filings for Q2 2021.